How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow. Nasdaq Listings Host Kristina Ayanian delves into companies' notable accomplishments, ...

The U.S. Education Department said on Thursday it was removing several "disparate impact" regulations, ‌which for decades have prohibited policies and practices with discriminatory impacts that are ...

Important: Double-check the numbers before submitting your entry. If an incorrect number is reported, you will not be able to edit it on your Student Center and will need to use the Student Personal ...